This update was written automatically with AI from market data and news wire reports, and published without review by a person.
Key Takeaways
- Moderna (MRNA) reported a massive Q3 earnings beat with an EPS of $0.38 (vs. expected loss of $1.09) and revenue of $1.31 billion, leading the company to raise its full-year revenue growth outlook to 15%-25%.
- President Trump reaffirmed his "100% support" for AI—which he has officially rebranded as "Super Intelligence" (SI)—stating that only "foolish leadership" would reject the technology.
- Charter Communications (CHTR) posted Q3 revenue of $14.9 billion and announced a new operating model aimed at saving $2 billion annually following its integration of Cox Communications.
- Tensions in the Strait of Hormuz escalated as the UKMTO reported a tanker attack involving waterline explosions near Khasab, while Iran demanded "practical moves" from the U.S. before resuming diplomacy.
- Markets are processing the aftermath of the U.S. midterm elections, with tech stocks sliding and the Bank of England (BoE) adopting a more hawkish stance on inflation.
Tech and Policy: Trump Doubles Down on "Super Intelligence"
President Trump took to Truth Social on Friday to declare his total support for the future of technology, stating he is "100% in favor of Super Intelligence." This follows a series of executive actions where the administration has moved to officially replace the term "Artificial Intelligence" with "Super Intelligence" (SI) in all federal documents. Trump criticized those hesitant to embrace the shift, remarking that "only foolish leadership" would say no to the advancements. The administration’s "Super Intelligence Force" continues to coordinate federal AI efforts, prioritizing American leadership in the sector over new regulatory hurdles.
Healthcare: Moderna Swings to Profit on International Demand
Moderna (MRNA) surprised Wall Street on Friday by reporting a profitable third quarter, driven by a 29% year-over-year revenue increase. The biotech giant recorded $1.31 billion in sales, significantly outperforming the $888.1 million analysts had projected. The beat was largely fueled by strong international demand for COVID-19 vaccines and the U.S. approval of mFLUSIVA, its new seasonal flu vaccine. Consequently, Moderna lowered its expected 2026 R&D expenses to $2.7 billion and improved its full-year revenue growth guidance from "up to 10%" to a range of 15%-25%.
Telecom: Charter Launches Growth Transformation
Charter Communications (CHTR) reported Q3 results that highlighted a strategic pivot toward efficiency and scale. While revenue of $14.9 billion slightly missed the $15.03 billion estimate, Adjusted EBITDA came in strong at $5.94 billion. CEO Chris Winfrey announced a new operating model designed to return the company to internet customer growth, targeting $2 billion in annualized expense savings. The company expects pro forma capital expenditures for the full year to reach approximately $13 billion as it continues to integrate assets from the Cox Communications acquisition.
Geopolitics: Maritime Attacks and Diplomatic Deadlock
Maritime security remains a critical concern as the United Kingdom Maritime Trade Operations (UKMTO) received reports of a tanker attacked with explosive devices attached to its hull near Khasab, Oman. The incident, which caused an engine room fire, occurred in the strategic Strait of Hormuz, a vital chokepoint for global oil supplies. Simultaneously, Ali Bagheri, deputy head of Iran's top security body, stated on state television that Tehran is not satisfied with "paper commitments" from Washington. Iran is reportedly demanding practical U.S. actions, such as the lifting of sanctions, before engaging in further diplomatic talks.
Automated market updates written with AI from market data and news wire reports, published without human review.